8-(ethoxymethyl)-1,4-dioxaspiro[4.5]decane | 1192737-88-4

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: 8-(ethoxymethyl)-1,4-dioxaspiro[4.5]decane
• CAS: 1192737-88-4
• 化学式: C₁₁H₂₀O₃
• 分子量: 200.278
• InChiKey: FXPMQBJJNLYVDO-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.4
• 重原子数：
  14
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  27.7
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为产物：
  描述：

  1,4-二噁螺[4.5]癸烷-8-甲醇 、 碘乙烷 以The title compound (0.340 g, 93%) was obtained as a light yellow oil, which的产率得到8-(ethoxymethyl)-1,4-dioxaspiro[4.5]decane
  参考文献：
  名称：

  NOVEL COMPOUNDS-300

  摘要：

  公式I的化合物或其药学上可接受的盐：其中R1、R2、R3、R4、m、n、q、s、t、X和Y的定义如规范中所述，以及包括化合物的盐和药物组合物的制备。它们在治疗中有用，特别是在疼痛管理中。

  公开号：

  US20090275574A1

文献信息

• Substituted 4-aminocyclohexane derivatives
  申请人：SCHUNK Stefan

  公开号：US20090215725A1

  公开（公告）日：2009-08-27

  Substituted 4-aminocyclohexane derivatives having the formula I: wherein R 1 -R 4 are as described herein, methods for their preparation, medicinal products and pharmaceutical compositions containing these compounds and the use of substituted 4-aminocyclohexane derivatives for treating pain.

  具有以下式I的4-氨基环己烷衍生物，其中R1-R4如本文所述，其制备方法，含有这些化合物的药物产品和药物组合物，以及用于治疗疼痛的4-氨基环己烷衍生物的用途。
• MUSCARINIC RECEPTOR AGONITS USEFUL IN THE TREATMENT OF PAIN, ALZHEIMER'S DISEASE AND SCHIZOPHRENIA
  申请人：AstraZeneca AB

  公开号：EP2285798A1

  公开（公告）日：2011-02-23
• ARGININE METHYLTRANSFERASE INHIBITORS AND USES THEREOF
  申请人：Epizyme, Inc.

  公开号：US20170291905A1

  公开（公告）日：2017-10-12

  Described herein are compounds of Formula (S-I), pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof. Compounds described herein are useful for inhibiting arginine methyltransferase activity. Methods of using the compounds for treating arginine methyltransferase-mediated disorders are also described.
• [EN] MUSCARINIC RECEPTOR AGONITS USEFUL IN THE TREATMENT OF PAIN, ALZHEIMER'S DISEASE AND SCHIZOPHRENIA<br/>[FR] AGONISTES DES RÉCEPTEURS MUSCARINIQUES UTILES DANS LE TRAITEMENT DE LA DOULEUR, DE LA MALADIE D'ALZHEIMER ET DE LA SCHIZOPHRÉNIE
  申请人：ASTRAZENECA AB

  公开号：WO2009136850A1

  公开（公告）日：2009-11-12

  Compounds of Formula (I), or pharmaceutically acceptable salts thereof: wherein R1, R2, R3, R4, m, n, q, s, t, X, and Y are as defined in the specification as well as salts and pharmaceutical compositions including the compounds are prepared. They are useful in therapy, in particular in the management of pain.